Quadrant Future-Tek's IPO was the talk of the town on its launch day. Within a few hours of its opening, the issue was fully subscribed. Today is Day 2 of the bidding. The IPO will conclude on Thursday, January 9.
The net proceeds from the IPO will be used to fund the company’s working capital requirements, repayment of outstanding working capital term loans, development of the Electronic Interlocking System for Railways, and other general corporate purposes.
08-Jan-2025 10:36:00
On Day 2, the IPO was subscribed 22.03 times, with
On Day 1, the IPO was subscribed 15.84 times with retail investors showing the highest interest with a subscription rate of 54.84 times. The subscription by Non-Institutional Buyers was 21.51 times and Qualified Institutional Buyers 5 times.
Quadrant Future Tek develops next-generation Train Control and Signalling Systems that ensure the safety of passengers. The company also operates a state-of-the-art Electron Beam Irradiation Centre, which produces speciality irradiated (E-beam) cables tailored to stringent industry standards. These cables serve sectors such as Railways, naval defence, renewable energy, and electric vehicles.
As of January 8, 2025, Quadrant Future Tek's IPO is exhibiting a strong Grey Market Premium (GMP) of Rs 210 per share. This suggests that the company's shares are trading at a 72.41% premium over the upper IPO price band of Rs 290, indicating a potential listing price of approximately Rs 500 per share.
Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market, nor we recommend or endorse trading in the grey market.
Year |
FY23 |
ROE |
61.76% |
ROCE |
27.19% |
EBITDA Margin |
17.37% |
PAT Margin |
9.10% |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here